The Chemours Company

NYSE:CC

Chemicals - Specialty

Basic Materials
$12.09 -1.20%

-$0.27 today

Market cap
$1.82B
Beta
1.39
P/E (TTM)
-8.0
EPS (TTM)
-$2.73
Dividend yield
1.61%
52W Low $10.14High $28.67

Volume 2.86M

Average 2.80M

CC Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

The Chemours CompanyNYSE: CC

Accounts Receivables · Q2 FY2026 · quarter ended Jun 2026

Accounts receivables growth accelerates

Q2 FY2026 accounts receivables of $218M (cash outflow) rose 246.0% year over year, ahead of the -61.5% change in trailing-twelve-month accounts receivables. Sequentially, it rose 183.1% from the prior quarter. Over 3 fiscal years it compounded at +5.2% a year.

Context

  • Accounts receivables amounted to 1.8% of revenue in FY2025, down 0.8 pp from a year earlier.
  • Accounts receivables increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +246.0% holds above the trailing-twelve-month pace of -61.5%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$218M+183.1% QoQ
Last fiscal yearDec 2025
$106M+169.7% YoY
LTMJun 2026
-$15M-61.5% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+246.0%——
1 year+169.7%——
3-year CAGR+5.2%——
5-year CAGR——
10-year CAGR——

Accounts Receivables history

USD · from the cash flow

Latest · FY2025
106M USD
Year-over-year change
+169.7%

Accounts Receivables vs competitors

How CC compares with its peers on the latest reported figures

  • CC's LTM Jun 2026 accounts receivables of $15M is the 14th largest of the 19 companies compared; the peer median is $37.63M.
  • Its year-over-year change of -61.5% is the 11th highest of 19, against a peer median of -27.9%.
  • Accounts receivables amounts to 0.3% of revenue for CC, versus a peer median of 1.4%.
CC Competitors Peer median
Accounts Receivables for CC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
LYBLyondellBasell Industries N.V.LTM Sep 2026$1.57B -334.1%-11.9%4.9%
LINLinde plcLTM Jun 2026$464M +887.2%-33.9%1.3%
WLKWestlake CorporationLTM Sep 2026$203M +2800.0%-64.1%1.8%
IFFInternational Flavors & Fragrances Inc.LTM Jun 2026$150M +400.0%-16.5%1.5%
APDAir Products and Chemicals, Inc.LTM Jun 2026$130.4M +138.0%-23.1%1.0%
FULH.B. Fuller CompanyLTM Aug 2026$78.97M +316.5%-48.2%2.2%
PPGPPG Industries, Inc.LTM Jun 2026$68M -82.2%-8.5%0.4%
KWRQuaker Chemical CorporationLTM Sep 2026$53.27M -696.2%—2.6%
WTTRSelect Water Solutions, Inc.LTM Sep 2026$52.81M -352.9%—3.5%
SXTSensient Technologies CorporationLTM Jun 2026$43.06M +310.8%-71.2%2.5%
AXTAAxalta Coating Systems Ltd.LTM Jun 2026$35M +284.2%—0.7%
ECVTEcovyst Inc.LTM Mar 2026$32.21M -2084.4%—3.9%
ESIElement Solutions IncLTM Sep 2026$31.9M -9.1%—0.9%
CCThe Chemours CompanyLTM Jun 2026$15M -61.5%+5.2%0.3%
OECOrion Engineered Carbons S.A.LTM Mar 2026$14.45M +243.8%—0.8%
PRMPerimeter Solutions, Inc.LTM Jun 2026$10.49M -46.7%+4.0%1.4%
FFFutureFuel Corp.LTM Mar 2026$5.44M -129.7%+57.9%4.9%
CBTCabot CorporationLTM Jun 2026$1M -98.5%—0.0%
ASHAshland Inc.LTM Jun 2026$0 -100.0%—0.0%
Peer median (excluding CC) $37.63M-27.9%-19.8%1.4%

Competitors are the stored peer set for CC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income608M578M(238M)86M(386M)
Depreciation & Amortization317M291M307M301M340M
Deferred Income Tax(77M)20M(158M)(27M)64M
Stock-Based Compensation34M27M19M15M21M
Change in Working Capital21M(103M)620M(1.05B)178M
Accounts Receivables(225M)91M0(152M)106M
Inventory(210M)(294M)58M(146M)(106M)
Accounts Payables281M105M(72M)(9M)(165M)
Other Working Capital175M(5M)634M(745M)343M
Other Non-Cash Items(89M)(58M)6M44M47M
Operating Cash Flow814M755M556M(633M)264M
Capital Expenditures(277M)(307M)(370M)(360M)(213M)
Acquisitions (Net)00007M
Purchases of Investments(12M)0000
Sales of Investments00000
Other Investing Activities509M23M141M7M0
Investing Cash Flow220M(284M)(229M)(353M)(206M)
Debt Repayment(208M)(80M)393M95M(61M)
Common Stock Issued0009M0
Common Stock Repurchased(173M)(495M)(69M)0(1M)
Dividends Paid(164M)(154M)(149M)(148M)(78M)
Other Financing Activities(9M)43M16M8M14M
Financing Cash Flow(554M)(686M)172M(36M)(126M)
Effect of Forex Changes(34M)(32M)4M(22M)27M
Net Change in Cash446M(247M)503M(1.04B)(41M)
Free Cash Flow537M448M186M(993M)51M

The Chemours Company

NYSE:CC

Intrinsic Alpha fair value

Locked

Current Price

$12.09

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.